1. Breast Cancer Drug Avastin Faces FDA Panel
For the second time in two years, a panel will go before the FDA's Center for Drug Evaluation and Research (CDER) to fight for the fate of the drug Avastin for breast cancer patients. In ... used for cancer of the lung, kidney, colon, and brain, but was granted provisional approval to treat breast cancer in 2008. Two studies showed that Avastin increased the length of time that women went without their symptoms getting worse. Genentech promised to continue research, but their first reported findings came as a great disappointment. Two studies showed that women did not live ... ...
- Word Count: 1317
- Approx Pages: 5
- Has Bibliography
- Grade Level: Undergraduate